7 Einträge gefunden

1. Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network

   1. Ludwig, Heinz
   2. Terpos, Evangelos
   3. van de Donk, Niels
   4. Mateos, Maria-Victoria
   5. Moreau, Philippe
   6. Dimopoulos, Melitios-Athanasios
   7. Delforge, Michel

   2023 - Forschungsinformationssystem des UKE
2. LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma

   1. Mateos, Maria-Victoria
   2. Weisel, Katja
   3. De Stefano, Valerio
   4. Goldschmidt, Hartmut
   5. Delforge, Michel
   6. Mohty, Mohamad
   7. Cavo, Michele

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network

   1. Ludwig, Heinz
   2. Sonneveld, Pieter
   3. Facon, Thierry
   4. San-Miguel, Jesus
   5. Avet-Loiseau, Hervé
   6. Mohty, Mohamad
   7. Mateos, Maria-Victoria

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Efficacy and safety profile of deep responders to carfilzomib-based therapy: a subgroup analysis from ASPIRE and ENDEAVOR

   1. Weisel, Katja
   2. Mateos, Maria-Victoria
   3. Gay, Francesca
   4. Delforge, Michel
   5. Cook, Gordon
   6. Szabo, Zsolt
   7. Desgraz, Renaud

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 study

   1. Dimopoulos, Meletios
   2. Quach, Hang
   3. Mateos, Maria-Victoria
   4. Landgren, Ola
   5. Leleu, Xavier
   6. Siegel, David
   7. Weisel, Katja

   2020 - Forschungsinformationssystem des UKE
6. Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studies

   1. Mateos, Maria-Victoria
   2. Spencer, Andrew
   3. Nooka, Ajay K
   4. Pour, Ludek
   5. Weisel, Katja
   6. Cavo, Michele
   7. Laubach, Jacob P

   2020 - Forschungsinformationssystem des UKE
7. Early M-protein Dynamics Predicts Progression-Free Survival in Patients With Relapsed/Refractory Multiple Myeloma

   1. Yan, Xiaoyu
   2. Xu, Xu Steven
   3. Weisel, Katja C
   4. Mateos, Maria-Victoria
   5. Sonneveld, Pieter
   6. Dimopoulos, Meletios A
   7. Usmani, Saad Zafar

   2020 - Forschungsinformationssystem des UKE